Friday, March 13, 2015 12:05:02 PM
I understand but.. and sorry for being a pain in the A$$ lol but I just feel strongly that no matter what an analyst placed for a price target prior, that after yesterdays conference call that (even with dilution of shares) those same analyst must see the potential, must see the broad clinical pipeline..etc..etc..
and finally, these analysts "MUST" understand that small biotechs cave into weak partnership deals because the small biotechs have no other choice.
Peregrine has another choice, they can say no, no and again no, because they have the foundation in PS Targeting that is required across the entire spectrum of medicine and they don't own 10% or 40% or just 75% of the pipeline. They own 100%. This is unheard of in a small biotech moving forward and growing. It simply just does not, ever, never happen.
Now if analysts don't realize this now, they are not so analytic.
I have an analogy and no beach or girls or glamorous as CP's : ) .. but lets take that car driving to the beach!
Now, how may people want into a car dealership to buy a car ? they simply think the dealer is being truthful and offering the best deal
Now, how many people have walked into the car dealership to buy a car but have done due diligence on what they should pay? so they walk away and get a call and settle on a little better price
Now, how many go to dozens of dealerships and ask dozens of questions on the same model, same color..etc and then go back a 2nd time to each of those dealerships to talk them down and still say no, no , no and walk away when "ONE" of those dealerships call back and finally realize this guy has done his homework and give him the best deal?
What Peregrine is doing is what "NO SMALL BIOTECH" has ever done with Big Pharma in making and striking a deal. They are not settling for what Big Pharma is used to dishing out and they are not quitting on sabotage like acts. They recovered and fighting back and damn, they will out maneuver Big Pharma this time.
Preferred shares - Big Pharma never had to worry about this
Collaborations of PPHM style - Big Pharma never dealt with this
Feds/Investigations & everyone watching - Big Pharma not used to this
Full manufacturing capabilities - Big Pharma not used to this
DMC monitoring live and 2 look-ins ? Damn, this is when people must realize that Big Pharma is out of their safety zone and as said, some Big Pharma empires beginning to crumble as no one has ever sat opposite of that conference table with as much leverage as Peregrine today has.
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM